Long-lasting injectable naltrexone for opioid addiction treatment
Injectable naltrexone 2-month depot formulations
This study is working on a new, easy-to-use injection of naltrexone that lasts for two months to help people with opioid addiction stick to their treatment and stay safe from overdose.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-10756971 on NIH RePORTER |
What this research studies
This research focuses on developing a new formulation of naltrexone, an effective medication for treating opioid addiction and preventing overdose. The goal is to create a 2-month injectable version that is easier for patients to use, addressing the common issue of noncompliance with current treatment methods. By utilizing advanced drug delivery systems, the research aims to enhance the medication's effectiveness and patient adherence. The project will involve rigorous testing to ensure the new formulation is safe and effective for long-term use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with opioid use disorders who are seeking effective treatment options.
Not a fit: Patients who are not struggling with opioid addiction or those who have contraindications to naltrexone may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more convenient and effective treatment option for individuals struggling with opioid addiction.
How similar studies have performed: Previous research has shown success with long-acting formulations of medications for addiction treatment, indicating potential for this approach.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Park, Kinam — Purdue University
- Study coordinator: Park, Kinam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.